Dear esteemed National Delegates,

It is my pleasure to provide you attached with the EANM procedure guidelines for radionuclide therapy with 177Lu-labeled PSMA-ligands (177Lu-PSMA-RLT) written under the lead of the EANM Oncology & Theranostics Committee.

As part of the EANM guideline review process, I kindly invite you to share this draft within your national society as appropriate and get back to me with your society’s collected comments, if any, by April 26, 2019at the latest.

Logg inn for å se vedlegget.

Vi søker etter overlege med spesialisering i nukleærmedisin og erfaring med PET-CT. Leger i spesialisering kan også søke, med nærmere angivelse av hva som gjenstår av spesialiseringen. Spesialisering i radiologi i tillegg er en fordel.

https://www.jucan.no/ledige-stillinger/Vestre-Viken/Medisin/3982819239?asidx=1&asid=2

To provide the treating physicians with accurate staging information, radiologists and nuclear medicine physicians should be aware of the updated classification system and should be cognizant of the site-specific strengths and limitations of FDG PET/CT. In this article, the eighth edition of the TNM staging system is reviewed, as well as the role of FDG PET/CT in the staging of non–small cell lung carcinoma.

https://pubs.rsna.org/doi/10.1148/rg.2018180060

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional nonprofit medical association that facilitates communication worldwide between individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985. SNMMI and EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine.

https://link.springer.com/article/10.1007/s00259-018-4129-6